Efficacy of repetitive transcranial magnetic stimulation in treatment-resistant depression: the evidence thus far

Repetitive transcranial magnetic stimulation for treatment-resistant depression

107 ISSN 1758-2008 10.2217/NPY.12.75 © 2013 Future Medicine Ltd Neuropsychiatry (2013) 3(1), 107–115 Harvard Longwood Psychiatry Residency Training Program, Boston, MA, USA Beth Israel Deaconess Medical Center, 330 Brookline Avenue – Rabb 2, Boston, MA 02115, USA Sentara Neurology Specialists, Norfolk, VA, USA *Author for correspondence: Tel.: +1 617 667 2300 ext. 14233; Fax: +1 617 667 5575; a...

Repetitive transcranial magnetic stimulation in the treatment of depression

BACKGROUND Transcranial magnetic stimulation (TMS)is a treatment for major depressive disorder that is otherwise resistant to treatment. Although world-leading research in TMS has been conducted in Australia, where it has had some availability for two decades, there is limited familiarity with the treatment in the general medical community. Availability, however, is increasing. OBJECTIVE The ...

Evidence Brief: Factors that Optimize Therapy with Repetitive Transcranial Magnetic Stimulation for Treatment-Resistant Depression

Repetitive transcranial magnetic stimulation: beyond the treatment of depression

*Consultant Psychiatrist, The London Psychiatry Centre, 72 Harley Street, London W1G 7HG, and Oxleas NHS Foundation Trust, London SE18 3RZ, UK; [email protected]

Repetitive transcranial magnetic stimulation for the treatment of depression.

Major depressive disorder (MDD) is one of the most prevalent mental illnesses in North America, affecting about 4% of Canadians annually. Although a number of effective treatments are available, as many as 30% of patients fail to respond to treatment and about 60% experience a relapse. These statistics emphasize the need for alternative treatment strategies to optimize outcomes, but few alterna...